Health economic evaluation of ferucarbotran-enhanced MRI in the diagnosis of liver metastases in colorectal cancer patients

International Journal of Colorectal Disease

Volumn 23, Issue 1, 2008, Pages 77-83

  Annemans, Lieven ^a,e,f   Lencioni, Riccardo ^b   Warie, Hans ^a   Bartolozzi, Carlo ^b   Ciceri, M Marco ^c   Müller, Ulrike ^d  

^a HEDM   (Belgium)

^b UNIVERSITY OF PISA   (Italy)

^c Schering Plough   (Italy)

^d BAYER PHARMA AG   (Germany)

^e GHENT UNIVERSITY   (Belgium)

^f FREE UNIVERSITY OF BRUSSELS   (Belgium)

Author keywords

Colorectal cancer; Diagnosis; Health economics; Liver metastases

Indexed keywords

FERUCARBOTRAN; SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURGERY; CASE MANAGEMENT; CLINICAL FEATURE; CLINICAL TRIAL; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DECISION TREE; DIAGNOSTIC IMAGING; HEALTH ECONOMICS; HUMAN; INTERMETHOD COMPARISON; LIFE EXPECTANCY; LIVER METASTASIS; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUALITY CONTROL; SIMULATION; SINGLE DRUG DOSE; SPIRAL COMPUTER ASSISTED TOMOGRAPHY;

COLORECTAL NEOPLASMS; CONTRAST MEDIA; COST SAVINGS; COST-BENEFIT ANALYSIS; DECISION TREES; EUROPE; HEALTH CARE COSTS; HUMANS; INJECTIONS, INTRAVENOUS; IRON; LIFE EXPECTANCY; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MODELS, ECONOMIC; OXIDES; PREDICTIVE VALUE OF TESTS; TOMOGRAPHY, SPIRAL COMPUTED; TREATMENT OUTCOME; UNNECESSARY PROCEDURES;

EID: 36348950263     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-007-0350-7     Document Type: Article

References (15)

1. Adam R, Lucidi V, Bismuth H (2004) Hepatic colorectal metastases: methods of improving resectability. Surg Clin North Am 84(2):659-671, Apr
2. Annemans L, Vanoverbeke N, Martin C. Cost of metastatic colorectal cancer (MCRC) in France and the UK: An incidence based approach. Paper presented at the 10th International Congress on Anti-cancer Treatment, Paris, France, Jan. 31-Feb. 3, 2000
3. Annemans L. Economic evaluation of oral chemotherapy in metastatic colorectal cancer. Oral presentation at the EAHP Congress, Amsterdam, March 22, 2001
4. Beard SM, Holmes M, Price C, Majeed AW (2000) Hepatic resection for colorectal liver metastases: A cost-effectiveness analysis. Ann Surg 232(6):763-776, Dec
5. Doubilet P, Begg CB, Weinstein MC, Braun P, McNeil BJ (1985) Probabilistic sensitivity analysis using Monte Carlo simulation. Med Dec Making 5(2):155-177
6. Drummond M, Stoddard M, Torrance G (1987) Economic evaluation of health care. Oxford Univ. Press, New York
7. Gazelle GS, Hunink MG, Kuntz KM, McMahon PM, Halpern EF, Beinfeld M, Lester JS, Tanabe KK, Weinstein MC (2003) Cost-effectiveness of hepatic metastasectomy in patients with metastatic colorectal carcinoma: A state-transition Monte Carlo decision analysis. Ann Surg 237(4):544-555, Apr
8. Helmberger T, Semelka R (2001) New contrast agents for imaging the liver. Magn Reson Imaging Clin N Am 9:745-766
9. Lencioni R, DellaPina C, Bruix J, Majno P, Grazioli L, Morana G, Filippone A, Laghi A, Bartolozzi C (2005) Clinical management of hepatic malignancies: Ferucarbotran-enhanced magnetic resonance imaging versus contrast-enhanced spiral computed tomography. Dig Dis Sci 50(3):533-537, Mar
10. Lencioni R, Cioni D, Crocetti L, Della Pina C, Bartolozzi C (2004) Magnetic resonance imaging of liver tumors. J Hepatol 40(1):162-171, Jan
11. Miller DK, Homan SM (1994) Determining transition probabilities: confusion and suggestions. Med Decis Making 14(1):52-58, Jan-March
12. Mori K, Scheidler J, Helmberger T, Holzknecht N, Schauer R, Schirren CA, Bittmann I, Dugas M, Reiser M (2002) Detection of malignant hepatic lesions before orthotopic liver transplantation: Accuracy of ferumoxides-enhanced MR imaging. Am J Roentgenol 179:1045-1051
13. Penna C, Nordlinger B (2003) Surgery and local treatments of liver metastases from colorectal cancer: How to improve results. Scand J Surg 92(1):90-96
14. Schultz JF, Bell JD, Goldstein RM, Kuhn JA, McCarty TM (1999) Hepatic tumor imaging using iron oxide MRI: Comparison with computed tomography, clinical impact, and cost analysis. Ann Surg Oncol 6(7):691-698, Oct-Nov
15. Simmonds PC, Primrose JN, Colquitt JL, Garden OJ, Poston GJ, Rees M (2006) Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer 94(7):982-999, Apr 10